| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. | Am J Med | 1994 | 2.89 |
| 2 | Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. | J Rheumatol | 1989 | 1.23 |
| 3 | Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients. | J Pharm Sci | 1989 | 1.16 |
| 4 | Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis. | J Rheumatol | 1990 | 0.98 |
| 5 | Effect of aspirin and sulindac on methotrexate clearance. | J Pharm Sci | 1990 | 0.87 |
| 6 | Biliary elimination of low-dose methotrexate in humans. | Arthritis Rheum | 1990 | 0.80 |
| 7 | Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate. | J Rheumatol | 1993 | 0.80 |
| 8 | Samarium-153-EDTMP in the treatment of refractory rheumatoid arthritis. | Scand J Rheumatol | 2001 | 0.75 |